Bank of America Corp. Reiterates “Underperform” Rating for Cochlear (COH)
Cochlear (ASX:COH)‘s stock had its “underperform” rating restated by analysts at Bank of America Corp. in a research report issued to clients and investors on Wednesday, Stock Ratings Network.com reports.
Cochlear (ASX:COH) traded up 0.32% on Wednesday, hitting A$59.350. The stock had a trading volume of 193,945 shares. Cochlear has a one year low of A$52.710 and a one year high of A$82.870. The stock’s 50-day moving average is A$58.85 and its 200-day moving average is A$63.13. The company has a market cap of A$3.378 billion and a price-to-earnings ratio of 25.46.
A number of other analysts have also recently weighed in on COH. Analysts at Credit Suisse reiterated an “underperform” rating on shares of Cochlear in a research note to investors on Thursday, September 26th. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. Cochlear has a consensus rating of “Hold” and a consensus price target of A$70.54 ($66.55).
Cochlear Limited (ASX:COH) is an Australia-based company, which operates in the implantable hearing device industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.